Patients and carers

  • Email
  • Help

Information for you

On this page, you will find information on the Agency’s activities that are most relevant to patients and carers, including news, and events.

You can contribute to the Agency’s work by responding to public consultations.

Learn more about how Patients and carers are actively involved in the work of the Agency.

Featured information

  • human newsletter

    Newsletter - Human medicines highlights

    This newsletter is addressed primarily to organisations representing patients, consumers and healthcare professionals. It provides a summary of key information relating to medicines for human use published by disease area during the previous month by the European Medicines Agency (EMA).

  • Patients at the heart of future innovation

    On 18 March 2015 EMA marked its 20th anniversary with a scientific conference entitled 'Science, Medicines, Health: Patients at the heart of future innovation'.

    Yann Le Cam (Chief Executive Officer, EURORDIS) was invited to represent the patients’ perspective on a panel discussion. Watch the video recording.

  • Preventing medication errors for high-strength/fixed-combination insulins

    The Pharmacovigilance Risk Assessment Committee (PRAC) raised concerns about a potential risk of medication errors following recent approval of high-strength insulins (higher than the EU-wide standard 100 units/ml concentration). The PRAC developed guidance that provides a strategy to proactively address this risk in a harmonised way across the EU. Patients were extensively consulted for input based on their practical experience. The draft guidance has been released for public consultation.

  • Beware of falsified medicines!

    Falsified medicines are fake medicines that may enter the supply chain illegally. Be careful about the way you buy medicines. For internet sales, there will be a logo to identify authorised online pharmacies and approved retailers providing authentic, authorised medicines. Read more about falsified medicines.

News for patients and carers

Events of interest

  • 03/06/2015

    EMA

    European Medicines Agency Human Scientific Committees' Working Party with Patients’ and Consumers’ Organisations (PCWP) meeting

    This is a meeting with representatives of the Patients' and Consumers' Organisations Working Party (PCWP). Patients and consumers will share their experiences on initiatives they are involved in and will discuss PCWP involvement in preparation of guidelines on the summary of clinical trial results for laypersons. Other topics such as the involvement of patient representatives in EMA committees, and FDA engagement with patients and the activities organised to mark the PCWP’s 10th anniversary will also be discussed. Registration by invitation only. ... Read more

  • 04/06/2015

    EMA

    European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting

    This is a joint meeting with representatives from patients’, consumers’ and healthcare professionals’ organisations. Participants will be updated on a number of topics including the European Commission study on off-label use, the EU Clinical Trial Portal and Database and the EU Network Strategy to 2020. Registration by invitation only. ... Read more

  • 01/07/2015 - 02/07/2015

    EMA

    Workshop on haemophilia registries

    Independent, disease-based registries are a potential source of valuable safety and efficacy data on products. The European Medicines Agency (EMA) is currently embarking on a strategy for patient registries. This initiative provides an appropriate starting point to consider what regulators need from haemophilia registries. The aim is to get the best capture of data in the European Union (EU) and build on existing expertise in this area. It is proposed to work with stakeholders on this topic, commencing with this EMA workshop. Places limited. Registration open until 01/06/2015. ... Read more

  • 30/04/2015

    EMA

    European Medicines Agency (EMA)/European Society for Medical Oncology (ESMO) Rare Cancers Europe initiative: Joint workshop on chordoma as a model for very rare cancers

    Following the workshop on the methodology of clinical trials in rare cancers held in October 2014, the European Medicines Agency (EMA) and the European Society for Medical Oncology (ESMO) Rare Cancers Europe initiative will review a real case scenario on one single rare cancer and discuss together how to facilitate the development of promising therapies in spite of rarity. The aim of this workshop, which focuses on chordoma, is to discuss scientific and regulatory evidence requirements for rare diseases, main challenges and identify possible methodological solutions that could work for this and other very rare cancers. The meeting foresees the participation of oncologists, statisticians, methodologists, patient advocates and industry. A meeting report will be published on the EMA and ESMO websites. Registration by invitation only. Places limited. ... Read more

  • 03/12/2015 - 04/12/2015

    EMA

    Innovation and Biomarkers in Cancer Drug Development (IBCD) 2015

    Innovation and Biomarkers in Cancer Drug Development (IBCD) 2015 will shine a spotlight on multi-stakeholder approaches to cancer drug development with new cancer biomarkers in a scientific programme which will include input from regulators, industry, academia, patients and payers. Without a doubt, the combined efforts of the European Organisation for Research and Treatment of Cancer (EORTC), an academic research organisation, the US National Cancer Institute (NCI), a governmental institution, the European Medicines Agency (EMA), a regulatory agency, and the American Association for Cancer Research (AACR), a professional scientific association, ensure that a unique programme focusing on multi-stakeholder approaches to cancer drug development will emerge. A rich scientific programme for IBCD 2015 has been developed covering topics of interest to all cancer drug development stakeholders. Registration open until 12/11/2015. ... Read more

  • See all Events of interest

Information for:

Find information for...

Medicines for elderly

ADR website spotlight

FAQ spotlight